Is overexpression of PSF1 correlated with poor prognosis in hepatocellular carcinoma patients?
These results suggest that the inhibition of PSF1 might provide new therapeutic approaches for HCC.
Since the clinical impact on transplant outcome seems as important as matching for histocompatibility antigens, genotyping of the IL-6 -174polymorphism may offer a new method for identifying patients at increased risk of allograft loss.